+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pertussis Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon


  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5463982
UP TO OFF until Jan 05th 2023
Pertussis pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Pertussis pipeline drugs and companies” presents key-decision makers with critical insights into Pertussis pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Pertussis pipeline Drug Snapshot, 2021

The Pertussis pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Pertussis. In addition to recent status, overview of drugs is included in the study. Wide range of Pertussis drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Pertussis drug development pipeline by phase

The Pertussis pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Pertussis pipeline candidates is provided in the report enables you to understand timetable developments in Pertussis therapeutic area.

Pertussis pipeline drug Technology, Licensing and Collaboration Details

Details of technologies used for development of Pertussis pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Pertussis research study. Companies looking to partner with other players are also detailed in the report.

Pertussis- mechanism of action of pipeline candidates

Pertussis pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Pertussis companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Pertussis drug administration.

Pertussis Drugs- Preclinical and Clinical Trials

This chapter in Pertussis preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Pertussis product area. Preclinical and clinical trial details of pipeline candidates for Pertussis are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Pertussis companies and Profiles

Companies developing Pertussis pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Pertussis Market Developments

The report presents the recent news and developments in the Pertussis pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Pertussis R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Pertussis pipeline drugs and clinical trials
  • Identify Pertussis drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Pertussis drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Pertussis pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Pertussis pipeline news, developments and insights

Scope of the Report

  • Disease overview including Pertussis symptoms, widely used treatment options, companies and other details are included
  • Pertussis Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Pertussis pipeline drug count by phase, company and mechanism of action
  • Pertussis companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Pertussis pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Pertussis companies including their business snapshot, business description and Pertussis pipelines are included.
  • Recent Pertussis market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Pertussis Disease overview
2.2 Companies investing in Pertussis industry
3 Pertussis Pipeline Snapshot, 2021
3.1 Pertussis Pipeline Drugs- Dominant phase type
3.2 Pertussis pipeline Drugs- Leading Mechanism of Action
3.3 Pertussis Pipeline Drugs- Widely researched Route of Administration
3.4 Pertussis Pipeline- New Molecular Entity
3.5 Pertussis pipeline- Companies, Universities and Institutes
4. Pertussis Drug Profiles
4.1 Current Status of Pertussis Drug Candidates, 2021
4.2 Pertussis Drugs in Development- Originator/Licensor
4.3 Pertussis Drugs in Development- Route of Administration
4.4 Pertussis Drugs in Development- New Molecular Entity (NME)
5. Pertussis Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Pertussis Companies and Universities
6.1 Leading Pertussis companies researching in drug development
6.2 Leading Pertussis Universities/Institutes investing in drug development
7. Pertussis News and Deals
7.1 Recent Pertussis Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact